The first histopathological evidence of trimetazidine for the prevention of contrast-induced nephropathy. [electronic resource]
Producer: 20141214Description: 575-80 p. digitalISSN:- 1525-6049
- Animals
- Antioxidants -- therapeutic use
- Body Weight
- Catalase -- metabolism
- Contrast Media -- adverse effects
- Creatinine -- blood
- Glutathione -- metabolism
- Kidney -- metabolism
- Kidney Diseases -- chemically induced
- Male
- Malondialdehyde -- metabolism
- Organ Size
- Rats, Wistar
- Superoxide Dismutase -- metabolism
- Trimetazidine -- therapeutic use
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.